Xiaojing Lin

Guiyang, 550004, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

MKRN1 suppresses cuproptosis in colorectal cancer through ubiquitin-dependent regulation of SLC31A1.

MKRN1 suppresses cuproptosis in colorectal cancer through ubiquitin-dependent regulation of SLC31A1.

Journal: Biological procedures online
Published: May 27, 2026

Prognostic model of ubiquitination-related genes in ovarian cancer based on transcriptomic analysis and experimental validation.

Prognostic model of ubiquitination-related genes in ovarian cancer based on transcriptomic analysis and experimental validation.

Journal: Frontiers in immunology
Published: June 26, 2025

Mechanism of ABCD3 inhibiting colorectal cancer progression by regulating Wnt/β-catenin.

Mechanism of ABCD3 inhibiting colorectal cancer progression by regulating Wnt/β-catenin.

Journal: Molecular biology reports
Published: April 09, 2025

Prognostic Value of Ubiquitination-Related Genes in Ovarian Cancer and Their Correlation With Tumor Immunity.

Prognostic Value of Ubiquitination-Related Genes in Ovarian Cancer and Their Correlation With Tumor Immunity.

Journal: Human mutation
Published: March 20, 2025

Preclinical and first-in-human of purinostat mesylate, a novel selective HDAC I/IIb inhibitor, in relapsed/refractory multiple myeloma and lymphoma.

Preclinical and first-in-human of purinostat mesylate, a novel selective HDAC I/IIb inhibitor, in relapsed/refractory multiple myeloma and lymphoma.

Journal: Signal transduction and targeted therapy
Published: October 02, 2024

Prognostic Model Associated with Necroptosis in Colorectal Cancer based on Transcriptomic Analysis and Experimental Validation.

Prognostic Model Associated with Necroptosis in Colorectal Cancer based on Transcriptomic Analysis and Experimental Validation.

Journal: Frontiers in bioscience (Landmark edition)
Published: November 10, 2023

Incidence, prognostic factors, and survival outcomes in patients with blastic plasmacytoid dendritic cell neoplasm: A retrospective study in the Surveillance, Epidemiology, and End Results database.

Incidence, prognostic factors, and survival outcomes in patients with blastic plasmacytoid dendritic cell neoplasm: A retrospective study in the Surveillance, Epidemiology, and End Results database.

Journal: European journal of haematology
Published: December 30, 2022

Silencing heme oxygenase-1 increases the sensitivity of ABC-DLBCL cells to histone deacetylase inhibitor in vitro and in vivo.

Silencing heme oxygenase-1 increases the sensitivity of ABC-DLBCL cells to histone deacetylase inhibitor in vitro and in vivo.

Journal: Oncotarget
Published: July 22, 2016

HIF-1α inhibition by 2-methoxyestradiol induces cell death via activation of the mitochondrial apoptotic pathway in acute myeloid leukemia.

HIF-1α inhibition by 2-methoxyestradiol induces cell death via activation of the mitochondrial apoptotic pathway in acute myeloid leukemia.

Journal: Cancer biology & therapy
Published: April 16, 2016

Overexpression of heme oxygenase-1 induced by constitutively activated NF-κB as a potential therapeutic target for activated B-cell-like diffuse large B-cell lymphoma.

Overexpression of heme oxygenase-1 induced by constitutively activated NF-κB as a potential therapeutic target for activated B-cell-like diffuse large B-cell lymphoma.

Journal: International journal of oncology
Published: March 05, 2016

Targeting of heme oxygenase-1 attenuates the negative impact of Ikaros isoform 6 in adult BCR-ABL1-positive B-ALL.

Targeting of heme oxygenase-1 attenuates the negative impact of Ikaros isoform 6 in adult BCR-ABL1-positive B-ALL.

Journal: Oncotarget
Published: September 16, 2015

Heme oxygenase-1 plays a crucial role in chemoresistance in acute myeloid leukemia.

Heme oxygenase-1 plays a crucial role in chemoresistance in acute myeloid leukemia.

Journal: Hematology (Amsterdam, Netherlands)
Published: July 29, 2015
Showing 1-12 of 14

Last Updated: 09/26/2026